Synapsoft logo
AI Insights from Disclosures
Searching...
IL DONG PHARMACEUTICAL CO., LTD. 249420
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
IL DONG PHARMACEUTICAL CO., LTD. engages in the manufacture and sale of pharmaceuticals, active pharmaceutical ingredients, health supplements, and special nutritional foods. The company's major pharmaceutical products include the Aronamin series of active vitamins and the antibiotic Flumarin, and it recorded consolidated revenue of KRW 303.249 billion for the first half of its 9th fiscal term.
Representative Director 윤웅섭, 이재준(공동 대표이사)
Founded August 1, 2016
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-6139277
Business number 803-88-00431
Phone Number 025263114
Fax Number 02-526-3045
Website www.ildong.com
Company Address 2 Baumoe-ro 27-gil, Seocho-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant